These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19307360)

  • 1. Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.
    Yeh RF; Rezk NL; Kashuba AD; Dumond JB; Tappouni HL; Tien HC; Chen YC; Vourvahis M; Horton AL; Fiscus SA; Patterson KB
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2367-74. PubMed ID: 19307360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).
    Else LJ; Taylor S; Back DJ; Khoo SH
    Antivir Ther; 2011; 16(8):1139-47. PubMed ID: 22155898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum.
    Bennetto-Hood C; Bryson YJ; Stek A; King JR; Mirochnick M; Acosta EP
    HIV Clin Trials; 2009; 10(1):41-7. PubMed ID: 19362995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.
    Mandelbrot L; Peytavin G; Firtion G; Farinotti R
    Am J Obstet Gynecol; 2001 Jan; 184(2):153-8. PubMed ID: 11174495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis.
    Dumond JB; Yeh RF; Patterson KB; Corbett AH; Jung BH; Rezk NL; Bridges AS; Stewart PW; Cohen MS; Kashuba AD
    AIDS; 2007 Sep; 21(14):1899-907. PubMed ID: 17721097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.
    Else LJ; Taylor S; Back DJ; Khoo SH
    Antivir Ther; 2011; 16(8):1149-67. PubMed ID: 22155899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women.
    Dumond JB; Nicol MR; Kendrick RN; Garonzik SM; Patterson KB; Cohen MS; Forrest A; Kashuba AD
    Clin Pharmacokinet; 2012 Dec; 51(12):809-22. PubMed ID: 23044523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.
    Aweeka FT; Hu C; Huang L; Best BM; Stek A; Lizak P; Burchett SK; Read JS; Watts H; Mirochnick M; Capparelli EV;
    HIV Med; 2015 Mar; 16(3):176-83. PubMed ID: 25407158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lopinavir/ritonavir trough concentrations with the tablet formulation in HIV-1-infected women during the third trimester of pregnancy.
    Calza L; Manfredi R; Trapani F; Salvadori C; Colangeli V; Borderi M; Grossi G; Motta R; Viale P
    Scand J Infect Dis; 2012 May; 44(5):381-7. PubMed ID: 22263609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus.
    Chappuy H; Tréluyer JM; Rey E; Dimet J; Fouché M; Firtion G; Pons G; Mandelbrot L
    Am J Obstet Gynecol; 2004 Aug; 191(2):558-62. PubMed ID: 15343237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.
    Bryson YJ; Mirochnick M; Stek A; Mofenson LM; Connor J; Capparelli E; Watts DH; Huang S; Hughes MD; Kaiser K; Purdue L; Asfaw Y; Keller M; Smith E;
    HIV Clin Trials; 2008; 9(2):115-25. PubMed ID: 18474496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women.
    Chappuy H; Tréluyer JM; Jullien V; Dimet J; Rey E; Fouché M; Firtion G; Pons G; Mandelbrot L
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4332-6. PubMed ID: 15504861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery.
    Gingelmaier A; Kurowski M; Kästner R; Eberle J; Mylonas I; Belohradsky BH; Friese K; Grubert TA
    AIDS; 2006 Aug; 20(13):1737-43. PubMed ID: 16931938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced lopinavir exposure during pregnancy.
    Stek AM; Mirochnick M; Capparelli E; Best BM; Hu C; Burchett SK; Elgie C; Holland DT; Smith E; Tuomala R; Cotter A; Read JS
    AIDS; 2006 Oct; 20(15):1931-9. PubMed ID: 16988514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy.
    Kwara A; Delong A; Rezk N; Hogan J; Burtwell H; Chapman S; Moreira CC; Kurpewski J; Ingersoll J; Caliendo AM; Kashuba A; Cu-Uvin S
    Clin Infect Dis; 2008 Mar; 46(5):719-25. PubMed ID: 18220480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.
    Baroncelli S; Villani P; Floridia M; Pirillo MF; Galluzzo CM; Cusato M; Amici R; Pinnetti C; Sabbatini F; Molinari A; Tamburrini E; Regazzi M
    Ther Drug Monit; 2008 Oct; 30(5):604-10. PubMed ID: 18728627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy-related effects on lamivudine pharmacokinetics in a population study with 228 women.
    Benaboud S; Tréluyer JM; Urien S; Blanche S; Bouazza N; Chappuy H; Rey E; Pannier E; Firtion G; Launay O; Hirt D
    Antimicrob Agents Chemother; 2012 Feb; 56(2):776-82. PubMed ID: 22106227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV.
    Momper JD; Best BM; Wang J; Capparelli EV; Stek A; Barr E; Badell ML; Acosta EP; Purswani M; Smith E; Chakhtoura N; Park K; Burchett S; Shapiro DE; Mirochnick M;
    AIDS; 2018 Nov; 32(17):2507-2516. PubMed ID: 30134297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of antiretrovirals in pregnant women.
    Mirochnick M; Capparelli E
    Clin Pharmacokinet; 2004; 43(15):1071-87. PubMed ID: 15568888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women.
    Ribeiro RMP; Moreira FL; Moisés ECD; Cavalli RC; Quintana SM; Lanchote VL; Duarte G
    Br J Clin Pharmacol; 2018 Oct; 84(10):2415-2421. PubMed ID: 29959798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.